Skip to main content

Peer Review reports

From: StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2

Original Submission
27 Sep 2023 Submitted Original manuscript
29 Dec 2023 Reviewed Reviewer Report - Xiangji Ying
4 Jul 2024 Reviewed Reviewer Report - Alfonso Piciocchi
12 Aug 2024 Author responded Author comments - Nina Deliu
Resubmission - Version 2
12 Aug 2024 Submitted Manuscript version 2
18 Sep 2024 Author responded Author comments - Nina Deliu
Resubmission - Version 3
18 Sep 2024 Submitted Manuscript version 3
Publishing
19 Sep 2024 Editorially accepted
15 Oct 2024 Article published 10.1186/s13063-024-08485-z

You can find further information about peer review here.

Back to article page